secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rani Therapeutics Holdings, Inc. (RANI)
CIK:        0001856725
Form:       8-K
Filed at:   2022-08-25T23:59:59+00:00
Accession:  0001193125-22-229280
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rani Therapeutics enters $150M ATM equity offering agreement with Cantor and H.C. Wainwright
--------------------------------------------------------------------------------

- Up to $150M of Class A common stock may be sold at market prices on Nasdaq through agents Cantor Fitzgerald and H.C. Wainwright.
- Agent compensation set at up to 3.0% of gross sales price per share sold.
- Offering under effective shelf registration (Form S-3, effective Aug 10, 2022); prospectus supplement filed Aug 24, 2022.
- Rani not obligated to sell any shares; agreement may be terminated by either party with 10 days' notice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1856725/000119312522229280/0001193125-22-229280-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1856725/000119312522229280/d385381d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-229280

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer